Case: Vaxart, Inc.
Venue: Northern District of Califotnia
Class Period: 6/25/2020 - 7/25/2020
Lead Plaintifff Deadline: 10/23/2020
Contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

NEW YORK, NY – July 27, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Vaxart, Inc. (“Vaxart” or the “Company”) (NASDAW: VXRT).

On June 26, 2020, Vaxart issued a press release announcing that the Company had been selected for Operation Warp Speed, the federal initiative to quickly develop drugs to combat Covid-19.  Reportedly, following this news a hedge fund that partly controlled the company walked away with more than $200 million in instant profits.

However, according to an article published by the New York Times on July 25, 2020, “Vaxart’s vaccine candidate was included in a trial on primates that a federal agency was organizing in conjunction with Operation Warp Speed[,]” but “Vaxart is not among the companies selected to receive significant financial support from Warp Speed to produce hundreds of millions of vaccine doses.”  

Following this news, Vaxart’s shares fell more than 22% in midday trading on July 27, 2020, the first trading day following the news.

If you purchased Vaxart shares and would like to discuss our investigation, please contact us by emailing This e-mail address is being protected from spambots. You need JavaScript enabled to view it or by calling (646) 315-9003.  

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Kaplan Fox & Kilsheimer LLP, with offices in New York, San Francisco, Los Angeles, Chicago and New Jersey, has many years of experience in prosecuting investor class actions. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.  If you have any questions about this investigation, your rights, or your interests, please contact: 

Frederic S. Fox
KAPLAN FOX & KILSHEIMER LLP
850 Third Avenue, 14th Floor
New York, New York 10022
(646) 315-9003
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
Fax:  (415) 772-4707
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it